Strategic Acquisitions Baxalta has been involved in strategic acquisitions such as being acquired by Shire in 2016 and subsequently acquired by Takeda. This history of mergers and acquisitions presents opportunities for cross-selling products and services to the expanded customer base under the new ownership.
Product Portfolio Expansion With investments in assets like the AAV8 vector and the development of therapies like Adynovate®, Baxalta is continuously expanding its product portfolio. Sales teams can leverage these new offerings to penetrate new markets and appeal to a wider range of customers.
Clinical Trial Initiatives The launch of multiple clinical trials by Baxalta, now part of Takeda, signals a proactive approach to research and development. Sales development representatives can use the success of these trials and the resulting therapies to engage with healthcare providers and demonstrate the company's commitment to innovation.
International Expansion Baxalta's presence in Northern Illinois provides an opportunity for sales professionals to tap into the US biotechnology market. By emphasizing the company's global reach and partnerships through acquisitions, sales teams can explore international sales opportunities and collaborations in the biotech sector.
Collaborative Partnerships Partnerships with companies like Nektar Therapeutics showcase Baxalta's collaborative approach to innovation. Utilizing these partnerships as a selling point, business development professionals can emphasize the synergies and combined expertise that can benefit potential clients and drive sales growth.
| Baxalta Email Formats | Percentage |
| First.Last@baxalta.com | 97% |
| LastF@baxalta.com | 2% |
| FLast@baxalta.com | 1% |
Biotechnology ResearchIllinois, United States10001+ Employees
Shire acquired Baxalta on June 3, 2016. Following this date, this page will no longer be actively monitored. There will be no updates or responses posted on this page. For continued news and updates, we encourage you to follow Shire on LinkedIn at https://www.linkedin.com/company/shire
Company Overview
Funding & FinancialsBaxalta's revenue is in the range of $1B
Funding & FinancialsBaxalta's revenue is in the range of $1B
1-888-653-2347 
support@leadiq.com